Pages that link to "Q24337832"
The following pages link to Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias (Q24337832):
Displaying 50 items.
- Ryanodine receptor 2 (Q3415811) (← links)
- Phosphodiesterase 4D (Q21106795) (← links)
- Phosphodiesterase 4D, cAMP specific (Q21496052) (← links)
- Ryanodine receptor 2, cardiac (Q21498437) (← links)
- FK506 binding protein 1b (Q21498459) (← links)
- Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy (Q24295360) (← links)
- Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases (Q24336808) (← links)
- Phosphodiesterase 4D Regulates Baseline Sarcoplasmic Reticulum Ca 2+ Release and Cardiac Contractility, Independently of L-Type Ca 2+ Current (Q24337525) (← links)
- MicroRNA dysregulation in diabetic ischemic heart failure patients (Q24618462) (← links)
- Beta-adrenoceptor stimulation potentiates insulin-stimulated PKB phosphorylation in rat cardiomyocytes via cAMP and PKA (Q24632097) (← links)
- Remodeling of ryanodine receptor complex causes "leaky" channels: a molecular mechanism for decreased exercise capacity (Q24649499) (← links)
- PDE4 inhibitors: current status (Q24651926) (← links)
- Cardiac cAMP: production, hydrolysis, modulation and detection (Q26781612) (← links)
- Imaging alterations of cardiomyocyte cAMP microdomains in disease (Q26785322) (← links)
- CaV1.2 signaling complexes in the heart (Q26828050) (← links)
- Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy (Q26995781) (← links)
- Therapeutic potential of PDE modulation in treating heart disease (Q27005761) (← links)
- PDE4 as a target for cognition enhancement (Q27008296) (← links)
- Mechanisms of altered Ca²⁺ handling in heart failure (Q27012758) (← links)
- A network-oriented perspective on cardiac calcium signaling (Q27023389) (← links)
- Compartmentalization of β-adrenergic signals in cardiomyocytes (Q27026992) (← links)
- BIN1 localizes the L-type calcium channel to cardiac T-tubules (Q27324852) (← links)
- Persistent cAMP-signals triggered by internalized G-protein-coupled receptors (Q27329609) (← links)
- Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors (Q27647620) (← links)
- Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety (Q27658795) (← links)
- A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia (Q28245373) (← links)
- Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart (Q28291007) (← links)
- FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells (Q28307493) (← links)
- Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes (Q28505912) (← links)
- Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases (Q28506771) (← links)
- Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice (Q28507989) (← links)
- Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes (Q28568737) (← links)
- AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway (Q28575625) (← links)
- Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias (Q28586317) (← links)
- Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4 (Q28590119) (← links)
- Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure (Q30495045) (← links)
- Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice (Q30497498) (← links)
- Functional antagonism of β‐adrenoceptor subtypes in the catecholamine‐induced automatism in rat myocardium (Q30498747) (← links)
- Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice (Q30548444) (← links)
- Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction (Q30596860) (← links)
- Axial tubule junctions control rapid calcium signaling in atria (Q30827621) (← links)
- Molecular inotropy mediated by cardiac miR-based PDE4D/PRKAR1α/phosphoprotein signaling (Q30828261) (← links)
- Dilated cardiomyopathy with increased SR Ca2+ loading preceded by a hypercontractile state and diastolic failure in the alpha(1C)TG mouse (Q33397715) (← links)
- Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts (Q33552229) (← links)
- Skeletal muscle Ca(2+) mishandling: Another effect of bone-to-muscle signaling (Q33602302) (← links)
- CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors (Q33611715) (← links)
- An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing (Q33654817) (← links)
- Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II (Q33769656) (← links)
- Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects (Q33966155) (← links)
- Cardiac ryanodine receptor phosphorylation: target sites and functional consequences (Q33995185) (← links)